Khosla Rachna at Amgen Inc. (AMGN) Sells 6,404 Shares
Khosla Rachna, of Amgen Inc. (NASDAQ:AMGN), sold 6,404 shares of company stock on August 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
01Khosla Rachna sold 6,404 shares of Amgen Inc. on August 13, 2026, at an average price of $416.43 per share, generating $521.4K in proceeds.
02Following the sale, Khosla Rachna still owns 6,404 shares of Amgen stock, and the same insider also purchased 7,656 shares on the same day for $204K.
03Amgen Inc. currently trades at $419.38 with a market capitalization of $209.2B, and insider sales alone do not necessarily indicate negative sentiment as executives commonly sell for tax planning or diversification.
04Recent insider activity shows mixed signals with both sales and purchases by multiple insiders within a four-day period in early August 2026.
Transaction Details
Khosla Rachna, of Amgen Inc. (NASDAQ:AMGN), sold 6,404 shares of company stock on August 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $416.43 per share, for a total transaction value of $521.4K. Following this transaction, Khosla Rachna still owns 6,404 shares of Amgen Inc. stock.
About Amgen Inc.
Amgen Inc.'s stock currently trades at $419.38, giving the company a market capitalization of $209.2B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
This $521K transaction is a notable data point for investors tracking insider sentiment at Amgen Inc. While any single trade should be viewed in context, patterns of insider activity over time can provide valuable directional signals.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Amgen Inc.
What does insider insider_sell mean for Amgen Inc. stock?
Insider insider_sells at Amgen Inc. (NASDAQ:AMGN) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.